Based in Manchester and established in 2006, Discovery 2 Medicine (D2M) has a world class “Scientific Advisory Board” able to provide specialist advice and assistance to SMEs and pre-commercial projects. Discovery 2 Medicine, having identified a real need for this kind of service, has assisted a significant number of projects and companies. The Board, acting as a team, is able to contribute to each individual problem identified by its customers. This makes Discovery 2 Medicine’s offering unique.
A schedule of services has been developed based on market demand that covers a wide range of offerings. These range from advice to specific technical services relating to specialist compound synthesis, computational modelling services, analytical expertise, as well as downstream offerings, post screening and well into lead optimisation and pre-clinical studies.
Discovery 2 Medicine is able to achieve such a wide range of services (from advice to technical assistance) because:
Moreover, Discovery 2 Medicine has assisted SMEs and more established companies in a wide range of therapeutic areas (see case studies) and beyond truly defined issues that relate from NCE to Medicine. D2M has proven and established expertise in the diagnostic areas and beyond. Discovery 2 Medicine is privileged to be working with some of the major players in UK Biotech today and tomorrow. Discovery 2 Medicine will deliver this broad basis of advice and specialist skills in a cost effective and timely manner and already has a proven track-record and a growing reputation in the field.
